Tibet AIM Pharm. Inc.

SZSE:002826.SZ

10.97 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Revenue 148.531139.041160.858188.55160.426128.738161.865205.005171.431264.967206.056199.276186.435207.315179.391180.549158.204199.294154.618152.6296.087206.074117.838123.404105.94152.78119.635125.62690.734115.4276.422110.02578.427140.63112.328144.18754.777111.66
Cost of Revenue 29.936.25950.30757.94163.76950.10368.756111.26295.467149.999112.938112.904104.862131.117109.624124.59199.622135.47592.21990.37967.822150.28666.7281.8672.055209.29756.41338.4728.48539.31819.05128.23522.19638.4332.09339.82821.198107.246
Gross Profit 118.632102.782110.551130.60996.65778.63593.1193.74375.964114.96893.11986.37281.57376.19869.76655.95858.58263.81962.39962.24228.26555.78851.11841.54433.885-56.51763.22287.15662.24976.10257.3781.7956.23102.20180.235104.3633.5794.413
Gross Profit Ratio 0.7990.7390.6870.6930.6030.6110.5750.4570.4430.4340.4520.4330.4380.3680.3890.310.370.320.4040.4080.2940.2710.4340.3370.32-0.370.5280.6940.6860.6590.7510.7430.7170.7270.7140.7240.6130.04
Reseach & Development Expenses 1.1973.4014.1077.6360.2712.0385.4355.740.49810.6120.4131.9011.0284.4651.1860.6935.0474.3751.1940.6780.62.5470.9321.0030.51413.779-0.9690.5323.0671.8440.6176.37202.17701.79200
General & Administrative Expenses 15.816-28.0932.9250.07214.136-13.97927.1893.5249.58216.31121.818-0.3219.437-2.07920.1443.3757.809-9.28310.405-1.1938.453-5.3288.347-0.7687.437-10.6438.362-3.92910.246-11.8398.412-0.1767.93811.08210.72-0.9469.5470
Selling & Marketing Expenses 87.77955.059100.32796.28774.77858.96568.89864.71254.76276.73867.37769.18557.37346.7146.75741.59237.50743.09742.75940.16916.84730.53136.26925.73618.921-59.47448.52865.04945.08151.80634.65155.58940.10967.38457.85371.00618.8160
SG&A 103.59526.969133.339110.60888.91444.98696.08768.23664.344100.11389.19668.86466.8144.63166.90144.96745.31633.81453.16438.97625.29925.20344.61624.96826.358-70.11756.88961.1255.32739.96843.06455.41348.04778.46568.57370.0628.3630
Other Expenses -7.2962.134-31.716-0.2570.0860.377-0.136-0.0932.483-22.369-8.06911.92.6912.587-0.482-0.37-0.359-0.383-0.295-0.1055.0050.397-0.313-0.5220.4721.861-0.150.437-0.0123.073-0.181-0.1010.0257.7644.6421.5822.53210.582
Operating Expenses 97.50292.504105.73118.24464.01973.45780.29889.05567.32688.35681.53982.66570.52951.9762.20351.43152.30438.77256.80351.72424.32224.51946.72234.89128.799-58.72457.85575.89956.05445.08143.74866.90649.682.1170.1882.06928.94910.582
Operating Income 21.1310.2784.58212.36532.394-6.6311.9257.51210.69826.61312.2234.04910.99225.2098.8437.8066.77925.7096.0748.9132.43128.0994.8927.4127.313.925-3.9519.8986.98427.10413.8417.7776.3815.957.54820.1753.47914.995
Operating Income Ratio 0.1420.0740.0280.0660.202-0.0510.0740.0370.0620.10.0590.020.0590.1220.0490.0430.0430.1290.0390.0580.0250.1360.0420.060.0690.091-0.0330.0790.0770.2350.1810.1620.0810.1130.0670.140.0640.134
Total Other Income Expenses Net -0.124-0.54-0.1751.3850.0860.377-0.136-0.093-0.0531.182-0.3662.11-0.0992.587-0.482-0.37-0.359-0.383-0.295-0.1055.0050.397-0.313-0.5220.4721.861-0.150.437-0.0123.186-0.181-0.115-0.1047.7644.6421.5282.11210.558
Income Before Tax 21.0069.7374.40713.75132.481-6.25311.7887.41910.64527.79511.8566.15910.89327.7968.3617.4366.4225.3265.7788.8087.43628.4964.5796.8917.77315.786-4.10110.3356.97230.19213.6617.6616.40423.71312.1921.7035.59125.552
Income Before Tax Ratio 0.1410.070.0270.0730.202-0.0490.0730.0360.0620.1050.0580.0310.0580.1340.0470.0410.0410.1270.0370.0580.0770.1380.0390.0560.0730.103-0.0340.0820.0770.2620.1790.1610.0820.1690.1090.1510.1020.229
Income Tax Expense 2.0784.8981.7051.8824.432.4222.041.2462.1663.162.5652.6092.2531.4951.3662.5181.1611.3281.8751.5871.4676.7780.9021.5231.2051.4820.4610.9710.8243.2341.4731.8860.8483.9391.1831.8970.819205.047
Net Income 18.7944.1092.17311.74727.899-8.5019.8075.7178.36422.899.2723.4468.52825.3446.9554.9185.25923.9993.9037.2215.96921.7183.6775.3676.56714.304-4.5629.3646.14926.95812.18715.7765.55619.77411.00719.8064.77122.92
Net Income Ratio 0.1270.030.0140.0620.174-0.0660.0610.0280.0490.0860.0450.0170.0460.1220.0390.0270.0330.120.0250.0470.0620.1050.0310.0430.0620.094-0.0380.0750.0680.2340.1590.1430.0710.1410.0980.1370.0870.205
EPS 0.10.0220.0120.0640.15-0.0460.0510.030.0440.120.0440.0160.040.120.040.0280.030.120.020.0360.030.120.020.0250.030.063-0.020.0460.030.130.060.0850.030.140.080.120.030.14
EPS Diluted 0.10.0220.0120.0640.15-0.0460.0510.030.0440.120.0440.0160.040.120.040.0280.030.120.020.0360.030.120.020.0250.030.063-0.020.0460.030.130.060.0850.030.140.080.120.030.14
EBITDA 21.2079.8894.5219.34238.067.70918.90313.95917.12125.24418.19812.3517.05535.31415.86713.09412.06725.76111.39512.2938.04529.2657.77810.4110.7995.3497.41412.9097.08133.33214.39217.886.673-244.67511.24424.3255.05-178.371
EBITDA Ratio 0.1430.0710.0280.1030.2370.060.1170.0680.10.0950.0880.0620.0910.170.0880.0730.0760.1290.0740.0810.0840.1420.0660.0840.1020.0350.0620.1030.0780.2890.1880.1630.085-1.740.10.1690.092-1.597